Correlation Between Spyre Therapeutics and Contextlogic
Can any of the company-specific risk be diversified away by investing in both Spyre Therapeutics and Contextlogic at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Spyre Therapeutics and Contextlogic into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Spyre Therapeutics and Contextlogic, you can compare the effects of market volatilities on Spyre Therapeutics and Contextlogic and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Spyre Therapeutics with a short position of Contextlogic. Check out your portfolio center. Please also check ongoing floating volatility patterns of Spyre Therapeutics and Contextlogic.
Diversification Opportunities for Spyre Therapeutics and Contextlogic
0.16 | Correlation Coefficient |
Average diversification
The 3 months correlation between Spyre and Contextlogic is 0.16. Overlapping area represents the amount of risk that can be diversified away by holding Spyre Therapeutics and Contextlogic in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Contextlogic and Spyre Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Spyre Therapeutics are associated (or correlated) with Contextlogic. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Contextlogic has no effect on the direction of Spyre Therapeutics i.e., Spyre Therapeutics and Contextlogic go up and down completely randomly.
Pair Corralation between Spyre Therapeutics and Contextlogic
If you would invest 739.00 in Contextlogic on June 1, 2025 and sell it today you would earn a total of 0.00 from holding Contextlogic or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 4.55% |
| Values | Daily Returns |
Spyre Therapeutics vs. Contextlogic
Performance |
| Timeline |
| Spyre Therapeutics |
| Contextlogic |
Risk-Adjusted Performance
Fair
Weak | Strong |
Spyre Therapeutics and Contextlogic Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Spyre Therapeutics and Contextlogic
The main advantage of trading using opposite Spyre Therapeutics and Contextlogic positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Spyre Therapeutics position performs unexpectedly, Contextlogic can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Contextlogic will offset losses from the drop in Contextlogic's long position.| Spyre Therapeutics vs. Marine Products | Spyre Therapeutics vs. Mesa Air Group | Spyre Therapeutics vs. Ferrari NV | Spyre Therapeutics vs. Wabash National |
| Contextlogic vs. Kenon Holdings | Contextlogic vs. Saia Inc | Contextlogic vs. Western Midstream Partners | Contextlogic vs. Aris Water Solutions |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Other Complementary Tools
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |